{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:40:39Z","timestamp":1791895239596,"version":"4.3.4"},"reference-count":146,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Oncol. Rev."],"abstract":"<jats:p>Lynch syndrome (LS) is an autosomal dominant disorder caused by germline mutations in DNA mismatch repair (MMR) genes. These mutations result in frameshift alterations, leading to the accumulation of errors within microsatellites. Individuals with LS have an elevated risk of developing colorectal and distant malignancies, including endometrial cancer (EC), which is one of the most common cancer associated with LS. Despite its significance, the association between EC and LS is often underexplored. Given the slow progression of colorectal cancer (CRC), there is an opportunity for early detection and intervention, which can aid in reducing both incidence and mortality through the identification and management of pre-malignant lesions and early-stage tumors in colorectum\/endometrium. Recognizing individuals with a heightened risk of CRC is essential for implementing personalized screening strategies. This review summarizes the original research work on LS to find out the correlation of CRC following an endometrial cancer diagnosis in individuals with MMR gene mutations, may involve refine treatment strategies and moreover this review may help clinicians and researchers to get an up-to date information on LS and its advanced treatment possibilities.<\/jats:p>","DOI":"10.3389\/or.2025.1549416","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T05:22:20Z","timestamp":1747372940000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["A brief review of Lynch syndrome: understanding the dual cancer risk between endometrial and colorectal cancer"],"prefix":"10.3389","volume":"19","author":[{"given":"Sneha","family":"Pallatt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibin","family":"Nambidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhamay","family":"Adhikary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antara","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surajit","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asim K.","family":"Duttaroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1053\/j.gastro.2022.08.058","article-title":"Lynch syndrome genetics and clinical implications","volume":"164","author":"Peltom\u00e4ki","year":"2023","journal-title":"Gastroenterology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"7904","DOI":"10.3390\/curroncol30090574","article-title":"An overview of endometrial cancer with novel therapeutic strategies","volume":"30","author":"Kuhn","year":"2023","journal-title":"Curr Oncol (Toronto, Ont.)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s10555-024-10172-z","article-title":"Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance","volume":"43","author":"Bhat","year":"2024","journal-title":"Cancer Metastasis Rev"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e2300332","DOI":"10.1200\/PO.23.00332","article-title":"Microsatellite instability is insufficiently used as a biomarker for Lynch syndrome testing in clinical practice","volume":"8","author":"Papadopoulou","year":"2024","journal-title":"JCO Precision Oncol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12935-019-1091-8","article-title":"Microsatellite instability: a review of what the oncologist should know","volume":"20","author":"Li","year":"2020","journal-title":"Cancer Cell Int"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41379-018-0136-1","article-title":"A practical guide to biomarkers for the evaluation of colorectal cancer","volume":"32","author":"Chen","year":"2019","journal-title":"Mod Pathol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.dnarep.2019.03.009","article-title":"The mismatch repair-dependent DNA damage response: mechanisms and implications","volume":"78","author":"Gupta","year":"2019","journal-title":"DNA repair"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1053\/j.gastro.2009.12.064","article-title":"Microsatellite instability in colorectal cancer","volume":"138","author":"Boland","year":"2010","journal-title":"Gastroenterology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"103338","DOI":"10.1016\/j.critrevonc.2021.103338","article-title":"The diverse molecular profiles of lynch syndrome-associated colorectal cancers are (highly) dependent on underlying germline mismatch repair mutations","volume":"163","author":"Helderman","year":"2021","journal-title":"Crit Rev Oncology\/Hematology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1002\/1878-0261.12772","article-title":"Physical activity, obesity and sedentary behavior in cancer etiology: epidemiologic evidence and biologic mechanisms","volume":"15","author":"Friedenreich","year":"2021","journal-title":"Mol Oncol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1158\/1055-9965.EPI-18-0264","article-title":"Cancer progress and priorities: uterine cancer","volume":"27","author":"Felix","year":"2018","journal-title":"Cancer Epidemiol Biomarkers and Prev"},{"key":"B12","doi-asserted-by":"publisher","first-page":"4102","DOI":"10.3390\/cancers14174102","article-title":"Lynch syndrome: from carcinogenesis to prevention interventions","volume":"14","author":"Gambini","year":"2022","journal-title":"Cancers"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/s0016-5085(99)70510-x","article-title":"New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC","volume":"116","author":"Vasen","year":"1999","journal-title":"Gastroenterology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/jnci\/djh034","article-title":"Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability","volume":"96","author":"Umar","year":"2004","journal-title":"JNCI J Natl Cancer Inst"},{"key":"B15","doi-asserted-by":"publisher","first-page":"827822","DOI":"10.3389\/fonc.2022.827822","article-title":"Impact of different selection approaches for identifying lynch syndrome-related colorectal cancer patients: unity is strength","volume":"12","author":"Fanale","year":"2022","journal-title":"Front Oncol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"16433","DOI":"10.3748\/wjg.v20.i44.16433","article-title":"Causes and consequences of microsatellite instability in gastric carcinogenesis","volume":"20","author":"Velho","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1038\/sj.onc.1206421","article-title":"Pathogenesis of DNA repair-deficient cancers: a statistical meta-analysis of putative Real Common Target genes","volume":"22","author":"Woerner","year":"2003","journal-title":"Oncogene"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.3390\/ijms24032137","article-title":"Genetic predisposition to colorectal cancer: how many and which genes to test?","volume":"24","author":"Rebuzzi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B19","article-title":"Lynch Syndrome. PubMed: StatPearls Publishing","author":"Bhattacharya","year":"2024"},{"key":"B20","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1002\/humu.22262","article-title":"Cancer risks for MLH1 and MSH2 mutation carriers","volume":"34","author":"Dowty","year":"2013","journal-title":"Hum Mutat"},{"key":"B21","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S2468-1253(23)00240-6","article-title":"Genetic predisposition to gastrointestinal polyposis: syndromes, tumour features, genetic testing, and clinical management","volume":"9","author":"Valle","year":"2024","journal-title":"The Lancet Gastroenterol and Hepatol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1001\/jama.2009.1529","article-title":"Risk of pancreatic cancer in families with Lynch syndrome","volume":"302","author":"Kastrinos","year":"2009","journal-title":"JAMA"},{"key":"B23","doi-asserted-by":"publisher","first-page":"979","DOI":"10.3390\/ijms19040979","article-title":"Lynch syndrome-related clear cell carcinoma of the cervix: a case report","volume":"19","author":"Nakamura","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B24","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/jnci\/djp473","article-title":"Risks of Lynch syndrome cancers for MSH6 mutation carriers","volume":"102","author":"Baglietto","year":"2010","journal-title":"JNCI: J Natl Cancer Inst"},{"key":"B25","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.respe.2008.03.117","article-title":"Cancer incidence and mortality in France over the period 1980-2005","volume":"56","author":"Belot","year":"2008","journal-title":"Revue d'epidemiologie et de sante publique"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/gim.2017.254","article-title":"MSH6 and PMS2 germ-line pathogenic variants implicated in Lynch syndrome are associated with breast cancer","volume":"20","author":"Roberts","year":"2018","journal-title":"Genet Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"001","DOI":"10.1055\/s-0042-1759888","article-title":"PMS2 pathogenic variant in lynch syndrome-associated colorectal cancer with polyps","volume":"10","author":"Poaty","year":"2023","journal-title":"Glob Med Genet"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1200\/JCO.2018.78.4777","article-title":"Cancer risks for PMS2-associated lynch syndrome","volume":"36","author":"Ten Broeke","year":"2018","journal-title":"J Clin Oncol : official J Am Soc Clin Oncol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1127329","DOI":"10.3389\/fonc.2023.1127329","article-title":"PMS2-associated Lynch syndrome: past, present and future","volume":"13","author":"Andini","year":"2023","journal-title":"Front Oncol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"104668","DOI":"10.1016\/j.yexmp.2021.104668","article-title":"The coding microsatellite mutation profile of PMS2-deficient colorectal cancer","volume":"122","author":"Bajwa-Ten Broeke","year":"2021","journal-title":"Exp Mol Pathol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1053\/j.gastro.2005.01.056","article-title":"Immunohistochemical analysis reveals high frequency of PMS2 defects in colorectal cancer","volume":"128","author":"Truninger","year":"2005","journal-title":"Gastroenterology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.cgh.2013.06.031","article-title":"History, genetics, and strategies for cancer prevention in Lynch syndrome","volume":"12","author":"Kastrinos","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S1470-2045(10)70265-5","article-title":"Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study","volume":"12","author":"Kempers","year":"2011","journal-title":"The Lancet Oncol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e1 e80","DOI":"10.1136\/flgastro-2022-102123","article-title":"Diagnosis and management of Lynch syndrome","volume":"13","author":"Edwards","year":"2022","journal-title":"Frontline Gastroenterol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1053\/j.gastro.2010.01.054","article-title":"Hereditary and familial colon cancer","volume":"138","author":"Jasperson","year":"2010","journal-title":"Gastroenterology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/s41416-019-0599-y","article-title":"Immune checkpoint inhibitors for the treatment of MSI-H\/MMR-D colorectal cancer and a perspective on resistance mechanisms","volume":"121","author":"Sahin","year":"2019","journal-title":"Br J Cancer"},{"key":"B37","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1159\/000531003","article-title":"The day-to-day practice of MMR and MSI assessment in colorectal adenocarcinoma: what we know and what we still need to explore","volume":"41","author":"Parente","year":"2023","journal-title":"Dig Dis (Basel, Switzerland)"},{"key":"B38","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1756-8722-6-22","article-title":"Lynch syndrome related endometrial cancer: clinical significance beyond the endometrium","volume":"6","author":"Wang","year":"2013","journal-title":"J Hematol and Oncol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1200\/jco.18.00283","article-title":"Microsatellite instability is associated with the presence of Lynch syndrome pan-cancer","volume":"37","author":"Latham","year":"2019","journal-title":"J Clin Oncol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1002\/ijgo.14969","article-title":"Molecular subtypes of endometrial cancer: implications for adjuvant treatment strategies","volume":"164","author":"Yang","year":"2024","journal-title":"Int J Gynecol and Obstet"},{"key":"B41","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41572-021-00324-8","article-title":"Endometrial cancer","volume":"7","author":"Makker","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"B42","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s12672-019-0358-9","article-title":"Estrogen signaling in endometrial cancer: a key oncogenic pathway with several open questions","volume":"10","author":"Rodriguez","year":"2019","journal-title":"Horm Cancer"},{"key":"B43","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA: A Cancer J Clinicians"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.3390\/cancers13092025","article-title":"A review of colorectal cancer in terms of epidemiology, risk factors, development, symptoms and diagnosis","volume":"13","author":"Sawicki","year":"2021","journal-title":"Cancers"},{"key":"B45","doi-asserted-by":"publisher","first-page":"264","DOI":"10.14740\/gr1062w","article-title":"Difference between left-sided and right-sided colorectal cancer: a focused review of literature","volume":"11","author":"Baran","year":"2018","journal-title":"Gastroenterol Res"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1038\/modpathol.2008.170","article-title":"Clinical significance of signet-ring cells in colorectal mucinous adenocarcinoma","volume":"21","author":"Sung","year":"2008","journal-title":"Mod Pathol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.3390\/cancers11071036","article-title":"Morphology and molecular features of rare colorectal carcinoma histotypes","volume":"11","author":"Remo","year":"2019","journal-title":"Cancers"},{"key":"B48","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10689-009-9290-4","article-title":"Evaluating Lynch syndrome in very early onset colorectal cancer probands without apparent polyposis","volume":"9","author":"Jasperson","year":"2010","journal-title":"Fam Cancer"},{"key":"B49","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.3390\/biomedicines10123207","article-title":"Hereditary colorectal cancer syndromes: molecular genetics and precision medicine","volume":"10","author":"Chen","year":"2022","journal-title":"Biomedicines"},{"key":"B50","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3390\/cancers15020451","article-title":"Menopausal status contributes to overall survival in endometrial cancer patients","volume":"15","author":"Barczy\u0144ski","year":"2023","journal-title":"Cancers"},{"key":"B51","doi-asserted-by":"publisher","first-page":"827724","DOI":"10.3389\/fendo.2022.827724","article-title":"Estrogen receptor function: impact on the human endometrium","volume":"13","author":"Yu","year":"2022","journal-title":"Front Endocrinol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"CD000402","DOI":"10.1002\/14651858.CD000402.pub4","article-title":"Hormone therapy in postmenopausal women and risk of endometrial hyperplasia","volume":"2012","author":"Furness","year":"2012","journal-title":"The Cochrane database Syst Rev"},{"key":"B53","doi-asserted-by":"publisher","first-page":"9828","DOI":"10.3748\/wjg.v20.i29.9828","article-title":"Genetic predisposition to colorectal cancer: where we stand and future perspectives","volume":"20","author":"Valle","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"e37266","DOI":"10.7759\/cureus.37266","article-title":"Risk of gynecological cancers in women with polycystic ovary syndrome and the pathophysiology of association","volume":"15","author":"Shetty","year":"2023","journal-title":"Cureus"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.3390\/cancers12071766","article-title":"Endocrine risk factors of endometrial cancer: polycystic ovary syndrome, oral contraceptives, infertility, tamoxifen","volume":"12","author":"Ignatov","year":"2020","journal-title":"Cancers"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1038\/ajg.2017.212","article-title":"Hereditary colorectal polyposis and cancer syndromes: a primer on diagnosis and management","volume":"112","author":"Kanth","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"otad077","DOI":"10.1093\/crocol\/otad077","article-title":"Diet and nutrition in inflammatory bowel disease: a review of the literature","volume":"6","author":"Manski","year":"2024","journal-title":"Crohn's and Colitis 360"},{"key":"B58","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s10552-021-01543-w","article-title":"Molecular mechanisms and differences in lynch syndrome developing into colorectal cancer and endometrial cancer based on gene expression, methylation, and mutation analysis","volume":"33","author":"Li","year":"2022","journal-title":"Cancer Causes and Control"},{"key":"B59","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.2174\/1381612827666210325105106","article-title":"ADAMTS9-AS2: a functional long non-coding RNA in tumorigenesis","volume":"27","author":"Xu","year":"2021","journal-title":"Curr Pharm Des"},{"key":"B60","doi-asserted-by":"publisher","first-page":"984013","DOI":"10.1155\/2010\/984013","article-title":"Genetics of endometrial cancers","volume":"2010","author":"Okuda","year":"2010","journal-title":"Obstet Gynecol Int"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1093\/jnci\/86.16.1216","article-title":"Microsatellite instability in sporadic endometrial carcinoma","volume":"86","author":"Duggan","year":"1994","journal-title":"JNCI J Natl Cancer Inst"},{"key":"B62","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jmoldx.2023.10.005","article-title":"MLH1 promotor hypermethylation in colorectal and endometrial carcinomas from patients with Lynch syndrome","volume":"26","author":"Helderman","year":"2024","journal-title":"The J Mol Diagn"},{"key":"B63","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/s12291-016-0601-x","article-title":"Geraniol inhibits endometrial carcinoma via downregulating oncogenes and upregulating tumour suppressor genes","volume":"32","author":"Shanmugapriya","year":"2017","journal-title":"Indian J Clin Biochem"},{"key":"B64","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s12094-007-0054-z","article-title":"Molecular determinants of invasion in endometrial cancer","volume":"9","author":"Abal","year":"2007","journal-title":"Clin and Translational Oncol Official Publ Fed Spanish Oncol Societies Natl Cancer Inst Mexico"},{"key":"B65","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2147\/AGG.S28953","article-title":"The genomics and genetics of endometrial cancer","volume":"2012","author":"O'Hara","year":"2012","journal-title":"Adv Genomics Genet"},{"key":"B66","doi-asserted-by":"publisher","first-page":"e1223","DOI":"10.1002\/ctm2.1223","article-title":"FGFR2 mutations promote endometrial cancer progression through dual engagement of EGFR and Notch signalling pathways","volume":"13","author":"Dixit","year":"2023","journal-title":"Clin Translational Med"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1038\/modpathol.2011.110","article-title":"FGFR2 alterations in endometrial carcinoma","volume":"24","author":"Gatius","year":"2011","journal-title":"Mod Pathol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1009345","DOI":"10.3389\/fonc.2022.1009345","article-title":"Mechanisms of mutant \u03b2-catenin in endometrial cancer progression","volume":"12","author":"Parrish","year":"2022","journal-title":"Front Oncol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1038\/modpathol.2013.96","article-title":"Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations, TP53 and microsatellite instability in endometrial cancer","volume":"26","author":"Bosse","year":"2013","journal-title":"Mod Pathol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1097\/pgp.0000000000000491","article-title":"High-grade endometrial carcinomas: morphologic and immunohistochemical features, diagnostic challenges and recommendations","volume":"38","author":"Murali","year":"2019","journal-title":"Int J Gynecol Pathol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1002\/(sici)1097-0142(20000215)88:4<814","article-title":"The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: evidence of distinct molecular genetic pathways","volume":"88","author":"Lax","year":"2000","journal-title":"Cancer"},{"key":"B72","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/pgp.0000000000000243","article-title":"TP53 mutational spectrum in endometrioid and serous endometrial cancers","volume":"35","author":"Schultheis","year":"2016","journal-title":"Int J Gynecol Pathol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s13669-013-0069-0","article-title":"Molecular pathogenesis of uterine serous carcinoma","volume":"3","author":"Nagase","year":"2014","journal-title":"Curr Obstet Gynecol Rep"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/j.ajpath.2011.01.009","article-title":"Somatic mutations of PPP2R1A in ovarian and uterine carcinomas","volume":"178","author":"Shih","year":"2011","journal-title":"The Am J Pathol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/j.1365-2559.2010.03673.x","article-title":"Endocervical\u2010like (M\u00fcllerian) mucinous borderline tumours of the ovary are frequently associated with the KRAS mutation","volume":"57","author":"Kim","year":"2010","journal-title":"Histopathology"},{"key":"B76","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1097\/01.pgp.0000152024.37482.63","article-title":"Mucinous ovarian tumors of Mullerian-type: an analysis of 17 cases including borderline tumors and intraepithelial, microinvasive, and invasive carcinomas","volume":"24","author":"Dub\u00e9","year":"2005","journal-title":"Int J Gynecol Pathol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3390\/cancers13010044","article-title":"HER2 status in high-risk endometrial cancers (PORTEC-3): relationship with histotype, molecular classification, and clinical outcomes","volume":"13","author":"Vermij","year":"2020","journal-title":"Cancers"},{"key":"B78","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.3390\/cancers16112100","article-title":"Implementation of HER2 testing in endometrial cancer, a summary of real-world initial experience in a large tertiary cancer center","volume":"16","author":"Plotkin","year":"2024","journal-title":"Cancers"},{"key":"B79","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/sj.bjc.6604814","article-title":"HER2 gene amplification and EGFR expression in a large cohort of surgically staged patients with nonendometrioid (type II) endometrial cancer","volume":"100","author":"Konecny","year":"2009","journal-title":"Br J Cancer"},{"key":"B80","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ygyno.2005.08.017","article-title":"Clinical significance of Her-2\/neu overexpression in uterine serous carcinoma","volume":"100","author":"D\u00edaz-Montes","year":"2006","journal-title":"Gynecol Oncol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1002\/1878-0261.13698","article-title":"ERBB2 mutations define a subgroup of endometrial carcinomas associated with high tumor mutational burden and the microsatellite instability-high (MSI-H) molecular subtype","volume":"18","author":"Brodeur","year":"2024","journal-title":"Mol Oncol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13148-020-00889-3","article-title":"The MLH1 polymorphism rs1800734 and risk of endometrial cancer with microsatellite instability","volume":"12","author":"Russell","year":"2020","journal-title":"Clin Epigenetics"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1177\/1947601911407325","article-title":"PTEN tumor suppressor network in PI3K-Akt pathway control","volume":"1","author":"Georgescu","year":"2010","journal-title":"Genes and Cancer"},{"key":"B84","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ebiom.2016.04.017","article-title":"Implications of genetic and epigenetic alterations of CDKN2A (p16(INK4a)) in cancer","volume":"8","author":"Zhao","year":"2016","journal-title":"EBioMedicine"},{"key":"B85","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.canlet.2017.03.029","article-title":"Oncogenic roles of DNA hypomethylation through the activation of cancer-germline genes","volume":"396","author":"Van Tongelen","year":"2017","journal-title":"Cancer Lett"},{"key":"B86","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.ogc.2004.08.008","article-title":"Hormonal regulation of implantation","volume":"31","author":"Kodaman","year":"2004","journal-title":"Obstet Gynecol Clin North America"},{"key":"B87","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00403-022-02339-x","article-title":"Tissue levels of suppressor of cytokine signaling-3 (SOCS-3) in mycosis fungoides","volume":"315","author":"Nada","year":"2022","journal-title":"Arch Dermatol Res"},{"key":"B88","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.3802\/jgo.2021.32.e79","article-title":"MLH1 promoter hypermethylation predicts poorer prognosis in mismatch repair deficiency endometrial carcinomas","volume":"32","author":"Kaneko","year":"2021","journal-title":"J Gynecol Oncol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/ijc.31300","article-title":"Three molecular pathways model colorectal carcinogenesis in Lynch syndrome","volume":"143","author":"Ahadova","year":"2018","journal-title":"Int J Cancer"},{"key":"B90","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1136\/gut.2004.048132","article-title":"Exon 3 beta-catenin mutations are specifically associated with colorectal carcinomas in hereditary non-polyposis colorectal cancer syndrome","volume":"54","author":"Johnson","year":"2005","journal-title":"Gut"},{"key":"B91","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.3892\/ol.2015.3728","article-title":"Polymorphisms of cell cycle regulator genes CCND1 G870A and TP53 C215G: association with colorectal cancer susceptibility risk in a Malaysian population","volume":"10","author":"Zahary","year":"2015","journal-title":"Oncol Lett"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1002\/ijc.23668","article-title":"IGF1 is a modifier of disease risk in hereditary non-polyposis colorectal cancer","volume":"123","author":"Reeves","year":"2008","journal-title":"Int J Cancer"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1002\/ijc.23177","article-title":"Aurora-A and Cyclin D1 polymorphisms and the age of onset of colorectal cancer in hereditary nonpolyposis colorectal cancer","volume":"122","author":"Talseth","year":"2008","journal-title":"Int J Cancer"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1007\/s10552-009-9416-x","article-title":"Genetic variants in the cell cycle control pathways contribute to early onset colorectal cancer in Lynch syndrome","volume":"20","author":"Chen","year":"2009","journal-title":"Cancer Causes and Control"},{"key":"B95","doi-asserted-by":"publisher","first-page":"3975","DOI":"10.1200\/JCO.2008.21.6853","article-title":"Clinical implications of the colorectal cancer risk associated with MUTYH mutation","volume":"27","author":"Lubbe","year":"2009","journal-title":"J Clin Oncol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1016\/j.ejca.2014.05.022","article-title":"Prevalence of germline MUTYH mutations among Lynch-like syndrome patients","volume":"50","author":"Castillejo","year":"2014","journal-title":"Eur J Cancer (Oxford, Engl : 1990)"},{"key":"B97","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1038\/s41388-022-02304-y","article-title":"MUTYH-associated tumor syndrome: the other face of MAP","volume":"41","author":"Magrin","year":"2022","journal-title":"Oncogene"},{"key":"B98","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3390\/jpm12020128","article-title":"Multi-omic approaches in colorectal cancer beyond genomic data","volume":"12","author":"Sardo","year":"2022","journal-title":"J Personalized Med"},{"key":"B99","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3892\/br.2023.1686","article-title":"Association of KRAS, NRAS, BRAF and PIK3CA gene mutations with clinicopathological features, prognosis and ring finger protein 215 expression in patients with colorectal cancer","volume":"19","author":"Wu","year":"2023","journal-title":"Biomed Rep"},{"key":"B100","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1101\/gad.293449.116","article-title":"Oncogenic Kras drives invasion and maintains metastases in colorectal cancer","volume":"31","author":"Boutin","year":"2017","journal-title":"Genes and Development"},{"key":"B101","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s12967-016-1053-z","article-title":"Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study","volume":"14","author":"Palomba","year":"2016","journal-title":"J Translational Med"},{"key":"B102","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3390\/ijms22010130","article-title":"Molecular mechanisms of colon cancer progression and metastasis: recent insights and advancements","volume":"22","author":"Malki","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B103","doi-asserted-by":"publisher","first-page":"3406","DOI":"10.3390\/cancers14143406","article-title":"Identification of lynch syndrome in patients with endometrial cancer based on a germline next generation sequencing multigene panel test","volume":"14","author":"Kim","year":"2022","journal-title":"Cancers"},{"key":"B104","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.immuni.2019.03.024","article-title":"Transforming growth factor-\u03b2 signaling in immunity and cancer","volume":"50","author":"Batlle","year":"2019","journal-title":"Immunity"},{"key":"B105","doi-asserted-by":"publisher","first-page":"3949","DOI":"10.3390\/cancers13163949","article-title":"The pathogenic role of PI3K\/AKT pathway in cancer onset and drug resistance: an updated review","volume":"13","author":"Rascio","year":"2021","journal-title":"Cancers"},{"key":"B106","doi-asserted-by":"publisher","first-page":"745187","DOI":"10.3389\/fonc.2021.745187","article-title":"The role of ARID1A in tumors: tumor initiation or tumor suppression?","volume":"11","author":"Xu","year":"2021","journal-title":"Front Oncol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.3390\/cells11142183","article-title":"Crucial role of oncogenic KRAS mutations in apoptosis and autophagy regulation: therapeutic implications","volume":"11","author":"Ferreira","year":"2022","journal-title":"Cells"},{"key":"B108","doi-asserted-by":"publisher","first-page":"533","DOI":"10.21873\/anticanres.13145","article-title":"The role of KRAS in endometrial cancer: a mini-review","volume":"39","author":"Sideris","year":"2019","journal-title":"Anticancer Res"},{"key":"B109","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.diff.2016.05.006","article-title":"Sox9 overexpression in uterine epithelia induces endometrial gland hyperplasia","volume":"92","author":"Gonzalez","year":"2016","journal-title":"Differentiation"},{"key":"B110","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13045-024-01563-4","article-title":"Wnt\/\u03b2-catenin signaling pathway in carcinogenesis and cancer therapy","volume":"17","author":"Song","year":"2024","journal-title":"J Hematol and Oncol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/ng.3127","article-title":"RNF43 is frequently mutated in colorectal and endometrial cancers","volume":"46","author":"Giannakis","year":"2014","journal-title":"Nat Genet"},{"key":"B112","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1002\/ijc.23508","article-title":"The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome","volume":"123","author":"Watson","year":"2008","journal-title":"Int J Cancer"},{"key":"B113","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1155\/2004\/391039","article-title":"Identification of HNPCC by molecular analysis of colorectal and endometrial tumors","volume":"20","author":"Vasen","year":"2004","journal-title":"Dis Markers"},{"key":"B114","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1136\/jcp.2009.064949","article-title":"Lynch syndrome (hereditary non-polyposis colorectal cancer) and endometrial carcinoma","volume":"62","author":"Garg","year":"2009","journal-title":"J Clin Pathol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"7944","DOI":"10.3748\/wjg.v21.i26.7944","article-title":"Familial colorectal cancer screening: when and what to do?","volume":"21","author":"Blanco","year":"2015","journal-title":"World J Gastroenterol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1200\/JCO.2012.47.6481","article-title":"Risk of colorectal cancer after diagnosis of endometrial cancer: a population-based study","volume":"31","author":"Singh","year":"2013","journal-title":"J Clin Oncol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s12029-011-9271-3","article-title":"Colorectal cancer screening in women with endometrial cancer: are we following the guidelines?","volume":"43","author":"Singh","year":"2012","journal-title":"J Gastrointest Cancer"},{"key":"B118","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1093\/jnci\/djs525","article-title":"Risks of colorectal and other cancers after endometrial cancer for women with Lynch syndrome","volume":"105","author":"Win","year":"2013","journal-title":"JNCI: J Natl Cancer Inst"},{"key":"B119","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.3390\/jcm10143127","article-title":"Colorectal cancer risk in women with gynecologic cancers-A population retrospective cohort study","volume":"10","author":"Liao","year":"2021","journal-title":"J Clin Med"},{"key":"B120","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s13046-023-02901-z","article-title":"CRISPR\/Cas9: a powerful tool in colorectal cancer research","volume":"42","author":"Hu","year":"2023","journal-title":"J Exp and Clin Cancer Res"},{"key":"B121","doi-asserted-by":"publisher","first-page":"6845","DOI":"10.1002\/cam4.3861","article-title":"Increased risk of second primary malignancies among endometrial cancer survivors receiving surgery alone: a population-based analysis","volume":"10","author":"Lai","year":"2021","journal-title":"Cancer Med"},{"key":"B122","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1002\/smll.201403126","article-title":"Efficient capture and simple quantification of circulating tumor cells using quantum dots and magnetic beads","volume":"11","author":"Min","year":"2015","journal-title":"Small"},{"key":"B123","doi-asserted-by":"publisher","first-page":"890908","DOI":"10.3389\/fonc.2022.890908","article-title":"Current and emerging prognostic biomarkers in endometrial cancer","volume":"12","author":"Njoku","year":"2022","journal-title":"Front Oncol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"713","DOI":"10.29252\/ijrm.14.11.713","article-title":"Correlation of CA-125 serum level and clinico-pathological characteristic of patients with endometriosis","volume":"14","author":"Karimi-Zarchi","year":"2016","journal-title":"Int J Reprod Biomed (Yazd, Iran)"},{"key":"B125","doi-asserted-by":"publisher","first-page":"4764","DOI":"10.3390\/cancers13194764","article-title":"HE4 as a biomarker for endometrial cancer","volume":"13","author":"Behrouzi","year":"2021","journal-title":"Cancers"},{"key":"B126","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2217\/whe.14.13","article-title":"Update on prognostic markers for endometrial cancer","volume":"10","author":"Binder","year":"2014","journal-title":"Women\u2019s Health (London, England)"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.3390\/cancers15051435","article-title":"HER2 amplification in p53-mutated endometrial carcinomas","volume":"15","author":"Balestra","year":"2023","journal-title":"Cancers"},{"key":"B128","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s44276-024-00043-z","article-title":"Protein prognostic biomarkers in stage II colorectal cancer: implications for post-operative management","volume":"2","author":"Alnakli","year":"2024","journal-title":"BJC Rep"},{"key":"B129","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nrc2645","article-title":"Genetic prognostic and predictive markers in colorectal cancer","volume":"9","author":"Walther","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"B130","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12885-022-09169-0","article-title":"An exploration of immunohistochemistry-based prognostic markers in patients undergoing curative resections for colon cancer","volume":"22","author":"Bennedsen","year":"2022","journal-title":"BMC Cancer"},{"key":"B131","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1136\/jclinpath-2015-202985","article-title":"High Ki67 expression is an independent good prognostic marker in colorectal cancer","volume":"69","author":"Melling","year":"2016","journal-title":"J Clin Pathol"},{"key":"B132","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s11888-011-0104-3","article-title":"Prognostic and predictive markers in colorectal cancer","volume":"7","author":"Reddy","year":"2011","journal-title":"Curr Colorectal Cancer Rep"},{"key":"B133","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3390\/cancers12020319","article-title":"Prognostic and predictive molecular biomarkers for colorectal cancer: updates and challenges","volume":"12","author":"Koncina","year":"2020","journal-title":"Cancers"},{"key":"B134","doi-asserted-by":"publisher","first-page":"4500","DOI":"10.3390\/cancers14184500","article-title":"Current approaches to the management of patients with endometrial cancer","volume":"14","author":"Kalampokas","year":"2022","journal-title":"Cancers"},{"key":"B135","doi-asserted-by":"publisher","first-page":"e000152","DOI":"10.1136\/bmjmed-2022-000152","article-title":"Endometrial cancer: molecular classification and future treatments","volume":"1","author":"Corr","year":"2022","journal-title":"BMJ Med"},{"key":"B136","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1136\/ijgc-2022-003675","article-title":"Immunotherapy in endometrial cancer","volume":"33","author":"Mahdi","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"B137","doi-asserted-by":"publisher","first-page":"495","DOI":"10.4240\/wjgs.v15.i4.495","article-title":"Current and emerging therapeutic approaches for colorectal cancer: a comprehensive review","volume":"15","author":"Kumar","year":"2023","journal-title":"World J Gastrointest Surg"},{"key":"B138","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.3390\/pharmaceutics14061213","article-title":"Promising therapeutic strategies for colorectal cancer treatment based on nanomaterials","volume":"14","author":"Krasteva","year":"2022","journal-title":"Pharmaceutics"},{"key":"B139","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41392-020-0116-z","article-title":"Comprehensive review of targeted therapy for colorectal cancer","volume":"5","author":"Xie","year":"2020","journal-title":"Signal Transduction Targeted Ther"},{"key":"B140","doi-asserted-by":"publisher","first-page":"10406","DOI":"10.1038\/s41598-024-59842-6","article-title":"Photocatalytic degradation of antibiotics and antimicrobial and anticancer activities of two-dimensional ZnO nanosheets","volume":"14","author":"Bhuin","year":"2024","journal-title":"Scientific Rep"},{"key":"B141","doi-asserted-by":"publisher","first-page":"1756284820917527","DOI":"10.1177\/1756284820917527","article-title":"Advances in immunotherapy for colorectal cancer: a review","volume":"13","author":"Golshani","year":"2020","journal-title":"Ther Adv Gastroenterol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s13337-022-00786-8","article-title":"Potential role of human papillomavirus proteins associated with the development of cancer","volume":"33","author":"Balaji","year":"2022","journal-title":"Virusdisease"},{"key":"B143","doi-asserted-by":"publisher","first-page":"4542","DOI":"10.1200\/JCO.2009.22.0764","article-title":"Use of hormone replacement therapy and the risk of colorectal cancer","volume":"27","author":"Rennert","year":"2009","journal-title":"J Clin Oncol"},{"key":"B144","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.7150\/jca.41943","article-title":"Estrogen receptor, progesterone receptor, and HER2 receptor markers in endometrial cancer","volume":"11","author":"Wang","year":"2020","journal-title":"J Cancer"},{"key":"B145","doi-asserted-by":"publisher","first-page":"5482","DOI":"10.3390\/ijms20215482","article-title":"The association and significance of p53 in gynecologic cancers: the potential of targeted therapy","volume":"20","author":"Nakamura","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B146","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.3748\/wjg.v21.i5.1457","article-title":"Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients","volume":"21","author":"Bae","year":"2015","journal-title":"World J Gastroenterol"}],"container-title":["Oncology Reviews"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/or.2025.1549416\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T05:22:20Z","timestamp":1747372940000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/or.2025.1549416\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,16]]},"references-count":146,"alternative-id":["10.3389\/or.2025.1549416"],"URL":"https:\/\/doi.org\/10.3389\/or.2025.1549416","relation":{},"ISSN":["1970-5557"],"issn-type":[{"value":"1970-5557","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,16]]},"article-number":"1549416"}}